Navigation Links
Zargis Cleared as Apple iPhone Developer; Medical Applications for Smartphones Planned
Date:10/21/2009

Corp. develops advanced diagnostic decision support products and services for primary care physicians, pediatricians, cardiologists and other healthcare professionals. Zargis was formed in 2001 when Siemens Corporate Research, a division of Siemens AG (NYSE: SI), and Speedus Corp. co-invested to develop and market an advanced acoustic technology designed to detect heart abnormalities identified through analysis of heart sounds.

For additional information about Zargis or Speedus Corp., contact Peter Hodge at 888.773.3669 (ext. 23) or phodge@zargis.com or visit the following Web sites: www.zargis.com and www.speedus.com.

Statements contained herein that are not historical facts, including but not limited to statements about the Company's product, corporate identity and focus, may be forward-looking statements that are subject to a variety of risks and uncertainties. There are a number of important factors that could cause actual results to differ materially from those expressed in any forward-looking statements made by the Company, including, but not limited to, the continuing development of the Company's sales, marketing and support efforts.

iPhone and Apple are registered trademarks of Apple Inc.

SOURCE Zargis Medical Corp.


'/>"/>
SOURCE Zargis Medical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Zargis Receives FDA Clearance for Signal X6 Telemedicine Device; OK Allows Delivery to US Army
2. Zargis Cardioscan(TM) Unveiled Through Global Marketing and Distribution Alliance With 3M Company
3. 3M and Zargis Announce Global Marketing Alliance
4. NBTY Acquisition of Julian Graves Unconditionally Cleared
5. Inverness Medical Innovations Launches New FDA Cleared C. DIFF QUIK CHEK COMPLETE(TM) Rapid Test
6. HemAway(R) Launches FDA-Cleared Painless Hemorrhoid Treatment Device
7. Mount Sinai first in US to implant FDA-cleared ring for mitral valve repair
8. Amedica Receives CE Mark for the Worlds First FDA-Cleared Valeo(TM) Ceramic Spinal Implant System
9. Clearwater's Canadian at-Home Dizziness Treatment Device Cleared by FDA
10. OneTouch(R) Ping(TM) Glucose Management System Cleared by FDA
11. Rejuvasun(TM) With Omnilux(TM): Industry First to Feature FDA-Cleared, Clinically Proven Light Therapy Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... 2015 , ... The United Nations Foundation today announced a ... for a select group of U.S.-based journalists during the week of November 9, ... International Conference on Family Planning in Bali. , In close coordination with ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... which provides vascular, electrocardiogram (EKG), echocardiogram, and NCV testing, announced their collegiate ... successfully identifying previously undiagnosed cardiovascular abnormalities one program at a time. ...
(Date:8/4/2015)... ... 04, 2015 , ... An article published July 27th by the ... method for encouraging people to lose weight. Specifically the study compared control patients with ... success, adding a financial incentive to the overall incentive of increased health. According to ...
(Date:8/4/2015)... ... August 04, 2015 , ... Bayco Products, Inc. announces a new ... for example, on hard hats that have a flip-up face shield. The sleek contours ... to work without having to remove their headlamp when raising or lowering their face ...
(Date:8/4/2015)... ... August 04, 2015 , ... It’s hard ... Medical & Day Spa in Santa Barbara, CA is offering the solution by ... that permanently eliminates sweat and odor glands in the underarms. This simple and ...
Breaking Medicine News(10 mins):Health News:UN Foundation Announces Press Fellowship to Indonesia with Focus on Women’s Health and Rights 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 2Health News:Colleges and High Schools Across the Country Are Joining the Wimbledon U Team Uncovering Unknown Cardiac Conditions and Promoting Heart Healthy Athletes 3Health News:Article on Incentivizing Weight Loss Mirrors Similar Motivations Surrounding Weight Loss Surgery, Says Dr. Feiz & Associates 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 2Health News:New Nightstick® NSP-4614B Dual-LightTM Headlamp fits more functionality into more places 3Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3
... Nutra ... to the Food and Drug Administration (FDA). This registration is considered the final step required ... for the treatment of chronic pain. , ... Plantation, FL (Vocus) December 7, 2009 -- Nutra Pharma Corp. (OTCBB: NPHC), a ...
... ... outlines important steps healthcare organizations should take to comply with requirements set forth in ... ... 2009 -- Data security experts at Kroll Fraud Solutions will host a ...
... hassles, study finds , MONDAY, Dec. 7 (HealthDay News) ... as effective in preventing dangerous venous clots as an old ... manage, a new study finds. , Dabigatran is marketed as ... yet approved for use in the United States. , The ...
... , ATLANTA, Dec. 7 ... (AED) Vimpat® that offer additional clinical evidence supporting the use ... partial-onset seizures. Results of presented research demonstrate sustained efficacy ... three years, and a consistent long-term tolerability profile. A ...
... , NEW YORK ... (SU2C) announced today that it is awarding $9.68 million to ... a three-year period, each investigator will receive a total of ... program, which supports the next generation of cancer research leaders. ...
... , DOYLESTOWN, Pa., Dec. 7 Patricia Scheller, ... at the Galen Institute,s "The Value of Innovation in Health ... 9th in Washington DC at the Columbus Club at Union ... research organization focusing on health and tax policy. , "I,m ...
Cached Medicine News:Health News:Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx -- Over-the-Counter and Prescription Treatments for Chronic Pain 2Health News:Nutra Pharma Completes FDA Submission for Nyloxin OTC and Nyloxin Rx -- Over-the-Counter and Prescription Treatments for Chronic Pain 3Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 2Health News:Kroll Fraud Solutions to Host Webinar for Healthcare Organizations on Achieving HITECH Compliance 3Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 2Health News:New Blood Thinner Could Replace Warfarin to Fight Venous Clots 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 2Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 3Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 4Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 5Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 6Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 7Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 8Health News:Stand Up To Cancer Funds High-risk/High-reward Cancer Research by 13 Young Scientists 9Health News:Prescient Medical, Inc. CEO Patricia Scheller to Speak at 'The Value of Innovation in Health Care,' a Galen Institute Conference 2
(Date:8/4/2015)...  Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX ),  a ... cancer, will be presenting at the 2015 Wedbush PacGrow Healthcare ... (10:55 a.m. PT) in New York . ... of Mirati, will provide a corporate overview. A ... the "Investors" page of Mirati,s corporate website at www.mirati.com ...
(Date:8/4/2015)... Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP ) today reported ... June 30, 2015 and updated its financial guidance for ... this morning, August 4, 2015, at 10:30 AM ET. ... by dialing (855) 582-8078. The conference ID is 90889796. ... revenues of $38.3 million, an increase of 118% as compared ...
(Date:8/4/2015)... 4, 2015  Ironshore Pharmaceuticals & Development, Inc. ... a company specializing in personalized medicine, to participate ... designed to evaluate the safety and efficacy of ... Attention-deficit/hyperactivity disorder (ADHD). This is Restore,s second clinical ... originally partnered with Ironshore in 2014 and continues ...
Breaking Medicine Technology:Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 2Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 2ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 3ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 4ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 5ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 6ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 7ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 8ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 9ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 10ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 11ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 12ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 13ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 14ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 15ANI Pharmaceuticals Reports Second Quarter and Year-To-Date 2015 Results and Highlights 16Restore Health Secures Another Clinical Trial with Ironshore Pharmaceuticals & Development 2
... Children whose eyes are misaligned and point outward are ... adulthood, according to findings of a Mayo Clinic study ... the American Academy of Pediatrics. , , ... 407 patients with strabismus (misaligned eyes) and compared them with ...
... expanding statin use broadly in wake of AHA-presented data ... Nov. 25 JUPITER, a clinical trial suggesting rosuvastatin may ... should not prompt universal statin use in older adults, according ... participants took part in the online poll conducted by medical ...
Cached Medicine Technology:Eye Divergence in Children Triples Risk of Mental Illness 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3
... Inc. (DAI) Myeloperoxidase (MPO) Enzyme-Linked Immunosorbent Assay ... semi-quantitative determination of IgG, A, M antibodies ... is used to detect antibodies in ... the assay are to be used as ...
Anti-RSV IgA Assay (ELISA)....
Anti-RSV IgG Assay (ELISA)....
Rapid Immunoassay for the detection of Respiratory Syncytial Virus....
Medicine Products: